tirzepatide semaglutide efficacy side effects vs Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks Tirzepatide Side Effects: Common &

In clinical studies of FDA-approved tirzepatide for weight management, participants experienced weight loss outcomes that, in some study populations, exceeded what was seen with semaglutide alone

Meslier V, et al

One study lasted 52 weeks and is considered to be the longest double-blind randomized trial to date for evaluating semaglutide for weight management

Many patients in both groups were already using GLP-1 RAs

BPC-157 comes in two forms: Subcutaneous injection Oral capsule Interestingly, BPC-157 is one of the only peptides available in an effective oral capsule form, likely because of its natural affinity for the gastrointestinal tract